The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer
Abstract CULLIN3‐based E3 ubiquitin ligase substrate‐binding adaptor gene SPOP is frequently mutated in prostate cancer (PCa). PCa harboring SPOP hotspot mutants (e.g., F133V) are resistant to BET inhibitors because of aberrant elevation of BET proteins. Here, we identified a previously unrecognized...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Nature
2019-09-01
|
| Serier: | EMBO Molecular Medicine |
| Fag: | |
| Online adgang: | https://doi.org/10.15252/emmm.201910659 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
